Anand Padmanabhan Presents a Case Series of HIT Patients with Negative Results in HIT ELISAs
Anand Padmanabhan, Professor and Consultant at Mayo Clinic, shared a post on LinkedIn:
“Excited to present a case series of HIT patients with NEGATIVE results in HIT ELISAs that use targets such as polyvinylsulfonate/PF4 and heparin/PF4, which are the commonest antigens used in HIT diagnostic kits. These antibodies activate platelets, and re-exposure of the patients to heparin based on these negative results ended in platelet counts dropping again, confirming HIT. This study emphasizes the importance of functional testing to make an accurate diagnosis especially in patients with a complex clinical course. I want to acknowledge colleagues from various institutions who contributed cases to this study. Have you seen such patients in your practice? Could this phenomenon be under-recognized?”
Title: Pathogenic PF4/Polyvinylsulfonate ELISA-negative Antibodies in HIT
Authors: Adam J. Kanack, Noah P. Splinter, Emily E. Mauch, Leben Tefera, Morayma Reyes Gil, Sakshi Jasra, Andrew Goodwin, Kristi J Smock, Hadiyah Ahmad, Aneel Ashrani, Nathaniel L. Robinson, Ana I. Casanegra, Curtis G. Jones, Shannon M. Pechauer, Erin Yttre, Richard H. Aster, Mindy C. Kohlhagen, Rachel R. Leger, David L. Murray, Lu Zhou, Demin Wang, Renren Wen, Dong Chen, Rajiv K. Pruthi, Anand Padmanabhan

Read full study here.
Stay informed with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
